WAYS TO GIVE
Become a Founding Underwriter
Founding Underwriters are responsible for the completion of key events that fulfill the core mission of Cardio Renal Foundation to replace dialysis and advance cardio renal care.
Create a major impact when you support these select opportunities to make a difference and change the way we treat heart and kidney health.
Support Founding Underwriter for Development Opportunities and Make a Major Impact on Cardio Renal Care
-
Founding Underwriter for Development: Molecule Engineering
Your donation supports the final engineering of the polymer molecule so that it absorbs the same amount of fluid as dialysis. The same target fluid volume that is removed in a typical dialysis session can be achieved through a safe, effective, non-invasive, alternate over-the-counter (OTC) approach.
Contact us to learn more about giving a major gift that supports the completion of molecule engineering. -
Founding Underwriter for Development: Performance Verification
Your donation supports bench testing of the polymer material to confirm it aligns with specifications and performs as expected in vitro.
Contact us to learn more about giving a major gift that supports the completion of performance verification of the polymer. -
Founding Underwriter for Development: Trial Batch
Your donation supports the manufacture of the first trial batch. The first trial batch will be used for subsequent safety and performance testing in animals and humans.
Contact us to learn more about giving a major gift that supports manufacturing of the first trial batch. -
Founding Underwriter for Development: Safety, Toxicology and Tolerability (Animals)
Your donation supports the validation of the polymer material for safety, toxicology, and tolerability in rats.
All nonclinical studies involving animals are conducted in compliance with Good Laboratory Practice (GLP) regulations (21 CFR Part 58).
Contact us to learn more about giving a major gift that supports the validation of non-human safety, toxicology and tolerability. -
Founding Underwriter for Development: Performance Validation (Animals)
Your donation supports the validation of the polymer material for performance in rats to confirm the material functions as intended in vivo.
All nonclinical studies involving animals are conducted in compliance with Good Laboratory Practice (GLP) regulations (21 CFR Part 58).
Contact us to learn more about giving a major gift that supports validation of non-human performance. -
Founding Underwriter for Development: Safety and Performance Validation (Human Test: Healthy Subjects)
Your donation supports the validation of the polymer material for safety and performance in healthy people to verify the polymer material is safe and functions as intended in people.
Contact us to learn more about giving a major gift that supports validation of human safety and performance. -
Founding Underwriter for Development: Safety and Performance Validation (Human Test: People with Early Stages 1-3 Chronic Kidney Disease)
Your donation supports the validation of the polymer material for safety and performance in people with chronic kidney disease to verify the material is safe and functions as intended in people along the entire chronic kidney disease spectrum, starting in its earliest stages.
Contact us to learn more about giving a major gift that supports validation of human safety and performance in people with Stages 1-3 of chronic kidney disease. -
Founding Underwriter for Development: Safety and Performance Validation (Human Test: People with End Stage Renal Disease (ESRD) on Hemodialysis)
Your donation supports the validation of the polymer material for safety and performance in ESRD patients on three-times weekly dialysis to verify the polymer material is safe and functions as intended in people on dialysis.
Contact us to learn more about giving a major gift that supports validation of human safety performance in people with ESRD on hemodialysis. -
Founding Underwriter for Development: First Commercial Batch
Your donation supports the manufacture of the first commercial batch. The first commercial batch will be made available affordably to people across the entire chronic kidney disease spectrum.
Use of the polymer material has the potential as the first-in-line standard of care to help prevent disease progression, and as a viable dialysis alternative instead of a machine.
Contact us to learn more about giving a major gift that supports manufacturing of the first commercial batch.